Literature DB >> 20431481

Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features.

David R Lucas1, Abhishek Shukla, Dafydd G Thomas, Rajiv M Patel, Anthony J Kubat, Jonathan B McHugh.   

Abstract

The dedifferentiated component of dedifferentiated liposarcoma shows wide histologic variation including tumors with heterologous differentiation. Myofibroblastic differentiation has been recognized in dedifferentiated liposarcoma. However, tumors closely resembling inflammatory myofibroblastic tumor have not. We report the clinicopathologic, immunohistochemical, and molecular finding in 6 cases of dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features treated at our institution. The tumors occurred mostly in middle age or elderly men, involved mostly the inguinal/scrotal region or retroperitoneum, and behaved aggressively. Microscopically, the dedifferentiated component closely resembled or, if taken out of context, was indistinguishable from inflammatory myofibroblastic tumor. All 3 major patterns seen in inflammatory myofibroblastic tumor (myxoid, cellular, and hypocellular fibrous) were represented. Areas resembling nodular fasciitis or desmoid fibromatosis were frequent findings. One tumor had heterologous osseous differentiation. In 4 tumors the inflammatory myofibroblastic tumor-like areas were diffuse, whereas in 2 they were combined with noninflammatory myofibroblastic tumor-like high-grade sarcoma. Five tumors stained for smooth muscle actin or desmin, none stained for ALK-1, 5 stained for MDM2, and 5 had amplified MDM2 by fluorescence in situ hybridization. Well-differentiated liposarcomatous components were present in every tumor. All patients developed locally recurrent or metastatic disease. At last follow-up 2 patients had died of disease and 2 were alive with disease. Dedifferentiated liposarcoma can have prominent inflammatory myofibroblastic tumor-like features, a finding that further expands its histologic spectrum. Awareness of this finding can prevent one from misdiagnosing dedifferentiated liposarcoma as inflammatory myofibroblastic tumor, a much less aggressive neoplasm.

Entities:  

Mesh:

Year:  2010        PMID: 20431481     DOI: 10.1097/PAS.0b013e3181db34d8

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Successful combination chemotherapy for metastatic inflammatory myofibroblastic tumor: A case report.

Authors:  Kyoko Inadomi; Hozumi Kumagai; Kotoe Takayoshi; Hiroshi Ariyama; Hitoshi Kusaba; Akihiro Nishie; Hidetaka Yamamoto; Ken Takase; Mamoru Tanaka; Kosuke Sagara; Yuta Okumura; Kenta Nio; Michitaka Nakano; Shuji Arita; Yoshinao Oda; Koichi Akashi; Eishi Baba
Journal:  Oncol Lett       Date:  2015-09-16       Impact factor: 2.967

2.  Dedifferentiated liposarcoma of the deep (paralaryngeal) soft tissue: lessons learnt from a case with a partly deceptively benign appearing dedifferentiated component.

Authors:  Fredrik Petersson; Euan Murugasu
Journal:  Head Neck Pathol       Date:  2013-07-06

Review 3.  Immunohistochemical Biomarkers of Mesenchymal Neoplasms in Endocrine Organs: Diagnostic Pitfalls and Recent Discoveries.

Authors:  Yin P Hung; Jason L Hornick
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

4.  Inflammatory myofibroblastic tumor of the thigh: presentation of a rare case and review of the literature.

Authors:  O D Savvidou; V I Sakellariou; O Papakonstantinou; E Skarpidi; P J Papagelopoulos
Journal:  Case Rep Orthop       Date:  2015-04-05

5.  Inflammatory myofibroblastic tumor of the thigh without bone involvement: a case report.

Authors:  Jun Lin; Hao Liu; Yin Zhuang; Peng Yang; Yifei Zheng; Yan Yang; Huilin Yang
Journal:  World J Surg Oncol       Date:  2014-07-15       Impact factor: 2.754

6.  Staged management of giant bilateral perinephric adipocytic neoplasms.

Authors:  Aileen Grace P Arriola; Edmund K Bartlett; Paul J Zhang; Kumarasen Cooper; Ali Naji; Robert E Roses
Journal:  Clin Case Rep       Date:  2017-03-23

7.  Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?

Authors:  Hui Liu; Qi Shen; Chung-Che Chang; Shimin Hu
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

8.  Primary intrathoracic liposarcomas: A clinicopathologic and molecular study of 43 cases in one of the largest medical centers of China.

Authors:  You Xie; Wenyi Jing; Wei Zhao; Ran Peng; Min Chen; Ting Lan; Heng Peng; Xin He; Huijiao Chen; Zhang Zhang; Hongying Zhang
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.